View Amendment Current Amendment: 2 to Bill 3825 Reps. Fry, Henderson, G. M. Smith propose the following Amendment No. 2 to H. 3825 (COUNCIL\VR\3825C001.CC.VR18):

Reference is to Printer's Date 3/8/18-H.

Amend the bill, as and if amended, SECTION 1, by striking Section 44-53-1655(A) and inserting:

/            "Section 44-53-1655.      (A)      The department shall develop and maintain as part of the prescription monitoring program a system to provide prescription report cards to practitioners to inform the practitioner about certain prescribing trends. The report card must provide, at a minimum:
           (1)      a comparison of the practitioner's number of prescriptions issued per month by therapeutic class code or by specific substances to peer averages by specialty throughout the State;
           (2)      a comparison of the practitioner's number of milligrams prescribed per month by therapeutic class code over by specific substances to peer averages by specialty throughout the State;
           (3)      the total number of patients receiving ninety morphine milligram equivalents (MMEs) or more a day;
           (4)      the total number of patients receiving opioid medications for thirty days or more;
           (5)      the total number of patients receiving opioids and benzodiazepines medications at the same time;
           (6)      the total number of patients issued prescriptions from three or more practitioners;
           (7)      the total number of patients filling prescriptions at three or more pharmacies;
           (8)      the total number of patients with controlled substance prescriptions whose dispensing dates overlap;
           (9)      the total number of patients obtaining refills on their prescriptions more than one week early; and
           (10)      the total number of prescription drug monitoring program queries made by the practitioner and a ratio of the queries to the number of patients or prescriptions issued.
     The report card also must provide data on the number of practitioners registered against which the comparisons of items (1) and (2) are being made and any other demographic data relating to the pool of practitioners and may include regional or nationwide prescribing comparison data that would be useful to the practitioner. Prescription report cards, and data, documents, records, and any other information accessed or compiled in preparing prescription report cards, are confidential and not subject to discovery, subpoena, or introduction into evidence in any civil action, unless confidentiality is waived by the practitioner.            /

Renumber sections to conform.
Amend title to conform.